P180025/S016: MANTA Vascular Closure Device
FDA’s recorded scope: a change to the microbiology test laboratory location for the MANTA product family
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 6 FDA records to the applicant name Teleflex Medical LLC. The collection includes 3 510(k) clearances. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 5, 2025 to Oct 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MGB appears in 3 of the 6 linked filings. The collection spans 4 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P180025, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 3015 Carrington Mill Blvd., Morrisville, NC, 27560, US. Recorded on K262531, decision dated Oct 27, 2026.
Instrument, Biopsy; Suture, Surgical, Absorbable, Polydioxanone; Suture, Nonabsorbable, Synthetic, Polyethylene; Device, Hemostasis, Vascular.
FDA’s recorded scope: a change to the microbiology test laboratory location for the MANTA product family
FDA’s recorded scope: a change in the location for final release testing of the MANTA Vascular Closure Device (VCD) product family
FDA’s recorded scope: a change to conduct the final release testing of the Manta VCD product family in a new location within the same facility
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Teleflex Medical LLC | 510(k) clearance | Oct 27, 2026 | FDA | |
| Teleflex Medical LLC | 510(k) clearance | Jul 9, 2026 | FDA | |
| Teleflex Medical LLC | 510(k) clearance | May 6, 2026 | FDA | |
MANTA Vascular Closure DeviceP180025/S016 | Teleflex Medical LLC | PMA supplement | Apr 23, 2026 | FDA |
MANTA Vascular Closure DeviceP180025/S015 | Teleflex Medical LLC | PMA supplement | Feb 27, 2026 | FDA |
| Teleflex Medical LLC | PMA supplement | Aug 5, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.